Marcelino Rivera, MD
Urology · Indianapolis, INNPI 1538454210
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.3%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 64.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $76,459, 5.4 times the $14,251 reported in 2019. Among urology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $819.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$111K
- Johnson & Johnson$30K
- Cook Incorporated$19K
- Lumenis, Inc$8K
- Cook Medical LLC$878
- Richard Wolf Medical Instruments Corp.$487
- plus $841 from 11 others
Across 24 payments — averaging $8808.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson$110K
- Boston Scientific$101K
- Urogen Pharma, Inc.$352
What the payments were for
- Royalty or licence$20,69412%
- Consulting fees$68,53540%
- Speaking & faculty fees$70,68341%
- Travel & lodging$4,8023%
- Food & beverage$6,5274%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 163 | $111,089 |
| Johnson & Johnson | 8 | $30,486 |
| Cook Incorporated | 6 | $19,093 |
| Lumenis, Inc | 1 | $8,403 |
| Cook Medical LLC | 11 | $878 |
| Richard Wolf Medical Instruments Corp. | 7 | $487 |
| Calyxo, Inc. | 2 | $279 |
| Kerecis Limited | 1 | $176 |
| Dornier Medtech America, Inc | 1 | $150 |
| Laborie Medical Technologies Corp. | 1 | $87 |
| Ambu Inc. | 1 | $71 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Urogen Pharma, Inc. | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
| Olympus America Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 2 | $6 |
| Biocomposites Inc | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$17,543
- Lumenis Pulse 120H$12,850
- GENERAL - THERAPIES$11,681
- Monarch Platform$9,604
- GENERAL BPH$8,800
- Moses 550 D\F\L$5,600
- LithoVue$3,143
- LITHO 150$2,648
- FIBER DUST$2,325
- Cook Medical Lasers$2,310
- Kerecis SurgiClose$702
- CVAC Aspiration System$279
- Cook$227
- NGage$225
- Kerecis GraftGuide$176
- Lithotripters & Accessories$150
- LithoVue Elite$116
How this compares
$171,277 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 78 | $48,974 |
| Potassium Citrate ErPotassium Citrate | 21 | $3,533 |
| Trospium Chloride | 17 | $1,365 |
| Tamsulosin Hcl | 85 | $896 |
| Chlorthalidone | 45 | $592 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 49 | $418 |
| Potassium Chloride | 23 | $293 |
| Finasteride | 20 | $237 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $164 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $129 |
| Ciprofloxacin Hcl | 18 | $50 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $40 |
Paid to pharmacies, not to this prescriber.
Other urology in Indianapolis
- Michael BorofskyIndianapolis$244K
- Helen BernieIndianapolis$100K
- Austen SladeIndianapolis$73K
- Jacob RustIndianapolis$57K
- Alvin WeeIndianapolis$46K
- Jason SprungerIndianapolis$30K
- Steven KheyfetsIndianapolis$18K
- Hristos KaimakliotisIndianapolis$12K
- Adri DurantIndianapolis$12K
- Thairo PereiraIndianapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.